Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-22

FDA Approved: HEMANGEOL — Supplemental Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA has approved a supplemental application for Hemangeol (propranolol hydrochloride) submitted by Eton Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEMANGEOL (Propranolol hydrochloride)

Snippet

SUPPL AP for HEMANGEOL (PROPRANOLOL HYDROCHLORIDE)